MedTrace Logo

Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin

NCT04749979 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-02-11

No results posted yet for this study

Summary

Estradiol valerate in the form of cycloprogenova™ (white tablet only) was started on day 2 or 3 of cycle with oral dose 4 mg divided on 2 doses in addition to Aspocid 75 mg once daily with folic acid 500 mcg once daily.

Conditions

Interventions

DRUG

Agonist (decapeptyl )

giving agonist

DRUG

HCG ( eg. Choriomon )

giving HCG

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER

  • Aljazeera Hospital

    lead OTHER

Principal Investigators

  • Mahmoud Alalfy, PhD · Algezeera hospitaland National Research Centre ,Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-05
Primary Completion
2021-06-25
Completion
2021-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04749979 on ClinicalTrials.gov